Ying Wan PhD Merck & Co., Inc.

Dr Ying Wan is a Senior Scientist in Vaccines Analytical Research & Development GxP Laboratories at Merck. She is a biochemist focused on innate immunity by training. She has 5 years of postdoctoral experience in vaccine analytics and formulation, and over 3 years of experience in vaccine analytical testing in GMP space. She has led the analytics and formulation development of various types of vaccine candidates including split virion, inactivated virus, live virus, and VLP, to facilitate novel vaccine candidates entering clinical trials. She is experienced in early clinical phase analytical method validation, vaccine potency assays, biophysical characterization, excipient screening, and real-time and accelerated stability studies. She is the subject matter expert for several compendial methods including visible particulates, color, clarity, and extractable volume of parenteral preparations in Merck Research Laboratories, Vaccines Analytical Research & Development.